Navigation Links
ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic 'Zapper' Said to Destroy Molluscum Contagiosum Pathogen
Date:3/20/2008

CHARLES TOWN, W.Va., March 20 /PRNewswire/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA; today announced that it has not only completed its development cycle of its highly secreted electronic treatment system for Molluscum Contagiosum, but has released it for sale on http://www.molluscum.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

"We have been successfully treating Molluscum with our proprietary nano-silver ointment for the past 4 years." says David B. Phillips, Ph.D., President of RBRM. "Although it has been the only painless treatment, it can take from 3 weeks to 3 months to achieve complete remission; now patients can begin to see success in as little as 3 days."

"We have priced the complete system at $299 so emotionally distraught parents can afford immediate relief." says Daena Carter, CFO of RBRM.

The system was recently featured on TV and can be viewed on the company's home page: http://www.molluscum.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions unde
'/>"/>

SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006
2. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
3. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
4. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
5. ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October
6. ReBuilder Medical Technologies, Inc. Announces Record Sales Month
7. ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment
8. ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support
9. ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand
10. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
11. ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... 2015 , ... To date, many pharmaceutical and biotech companies ... benefits, allowing them to gain access to capabilities that cannot be found in-house, ... get access to innovation and ensure timely introduction of product into the market. ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... largest online retailer of nutritional supplements, has officially opened the polls for ... awards in the following categories:, ,     Brand of the ...
(Date:8/3/2015)... ... 2015 , ... The art of preparing and cooking food comes naturally to ... young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that she ... My Persian Kitchen with the world. , Since Americans tend to be undereducated about ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... to Ahjumawi Lava Springs, California’s northernmost and among its least visited State Parks. ... water aquifers, whose main outflow is at Ahjumawi Lava Springs, part of the ...
(Date:8/3/2015)... ... 2015 , ... From 2006-2017 the number of dental laboratories ... research compiled for the National Association of Dental Laboratories ( NADL ) by ... Labor Statistics. As the number of dental laboratories decreases, dentists will have fewer ...
Breaking Medicine News(10 mins):Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3
... by Television Week for providing "vital information" to ... television program that tells the compelling and inspirational stories of ... markets: Denver, CO; Albany, NY; Austin, TX; Salt Lake City, ... all, the program now airs on nearly 260 television stations ...
... Improve Your Heart Health Through Proper Oral Care WASHINGTON, ... throughout the U.S. will be making personal pledges to ... initiative and promote heart health awareness, WomenHeart has partnered ... campaign. Heart Promises will focus on empowering ...
... Was Financially Untenable -LOS ANGELES, Feb. 9 According ... explanations offered for the closing of the Motion Picture ... up, raising questions about the underlying reasons for displacing ... live out their lives at the facility.The story by ...
... to learn about Heart Failure-how to prevent it and to ... Week February 8-14, 2009 Heart Failure Society of ... Available at www.abouthf.org NEW YORK, ... for February 8-14. This is a time for ...
... 9 Global multiservice public relations,agency Waggener ... panel discussion,titled "Healthcare Communications in the Digital ... Environment." The presentation will take place on,Tuesday, ... company,s Washington, D.C., office and be,available via ...
... to Discuss Results - EXTON, Pa., Feb. 9 ... that its Phase 3 trial evaluating maribavir used as ... (SCT) patients did not achieve its primary endpoint. In ... between maribavir and placebo in reducing the rate of ...
Cached Medicine News:Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 2Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 3Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 4Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 5Health News:'Sharing Miracles' Television Program Expands Network to Key U.S. Markets 6Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 2Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 3Health News:WomenHeart Celebrates American Heart Month With Heart Promises Campaign 4Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 2Health News:National Heart Failure Awareness Week February 8-14, 2009: Visit www.abouthf.org to Learn More About Heart Failure 3Health News:Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 2Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 3Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 4Health News:ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients 5
(Date:8/3/2015)... 2015 /OFF HOLD OFF ... PIV757417 The following release: "Biotech Advancements Coupled with ... & Treatments for Critical-Care Patients With Severe Wound ... Aug 2015 12:30 GMT Cooperative research ... research and top-tier universities for identifying biotech solutions ...
(Date:8/3/2015)...  Charleston Laboratories, Inc., an emerging specialty pharmaceutical ... program with a Phase 1 study on its ... contains fast-dissolving promethazine and sumatriptan.  This novel migraine ... migraine headache pain and migraine-induced nausea and vomiting ... headaches also suffer from nausea and vomiting," said ...
(Date:8/3/2015)... , August 3, 2015 BiondVax ... the statistical analysis of results from a study which demonstrates ... phase II trial which took place in 2012, provided participants ... at the time of the study- in particular the current ... in the United States in 2015. ...
Breaking Medicine Technology:/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3
... N.J., May 7 In letters to Senate Special ... Finance Committee Ranking Member Charles Grassley (R-IA), Johnson & ... Sunshine Act of 2009 (S. 301). The company also ... by its U.S. pharmaceutical, medical device and diagnostics companies."We ...
... at American Pain Society Annual Meeting-BALTIMORE, May 7 ... stage biotechnology company that develops pain therapies, today ... lead candidate, ARC-4558, significantly reduced pain caused by ... abstract will be presented in a poster session ...
Cached Medicine Technology:Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 2Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009 3Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy 2Arcion Therapeutics' Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: